EVP AND GENERAL COUNSEL of Bausch Health Inc (30-Year Financial, Insider Trades) Christina Ackermann (insider trades) bought 4,390 shares of BHC on 03/10/2020 at an average price of $18.25 a share. The total cost of this purchase was $80,118.
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices. Bausch Health Companies Inc has a market cap of $6.53 billion; its shares were traded at around $18.45 with and P/S ratio of 0.80. Bausch Health Companies Inc had annual average EBITDA growth of 15.70% over the past ten years. GuruFocus has detected 3 severe warning signs with Bausch Health Companies Inc. .
Directors and Officers Recent Trades:
- EVP AND GENERAL COUNSEL Christina Ackermann bought 4,390 shares of BHC stock on 03/10/2020 at the average price of $18.25. The price of the stock has increased by 1.1% since.
- Director Eschenbach Andrew C. Von bought 1,100 shares of BHC stock on 03/10/2020 at the average price of $18.18. The price of the stock has increased by 1.49% since.
- Director Schutter Richard U De bought 8,800 shares of BHC stock on 03/10/2020 at the average price of $21. The price of the stock has decreased by 12.14% since.
For the complete insider trading history of BHC, click here
.
